Artículos del autor

solaci

Scientific Articles COVID-19

Efficacy of the Novavax Vaccine Against COVID-19: Nanoparticle Technology to the Test

In healthy adults, two doses of the NVX-CoV2373 (Novavax) vaccine has an efficacy of almost 90% against...
solaci -
Acute coronary syndromes

Ticagrelor or Prasugrel for Acute Patients Who Undergo Angioplasty

We are still asking the same question: ticagrelor or prasugrel? With narrow margins between these drugs in...
solaci -
Femoropopliteal

Discrepancy between Angina and Ischemia Repeats in Peripheral Artery Disease

Three randomized studies showed exercising significantly improves 6-minute walk outcomes in patients with peripheral artery disease (PAD)....
solaci -
Coronary disease

Novel DES Technology Promises to Become the Next DES Generation

The novel technology of drug-eluting stent Supreme was designed to synchronize antiproliferative drug release and leave a...
solaci -
Scientific Articles COVID-19

Janssen: Efficacy of the Only Single Dose Vaccine against COVID-19

One single dose of the Ad26.COV2.S vaccine (Janssen) will protect you against symptomatic and asymptomatic SARS-CoV-2 infection....
solaci -
Aorta

Abdominal Aortic Aneurysm during the Pandemic: Should They Be Operated or Deferred?

Some European societies have recommended deferring the treatment of infrarenal abdominal aortic aneurysm (AAA) ≥5.5 cm during the...
solaci -
Institutional News

SOLACI Webinar | Minimalist TAVI III Summit: A Meeting with the Experts

solaci -
Institutional News

Watch Again our Masterclass on “How to Engage with the Industry to Promote MIL?”

Watch again our Masterclass on "How to Engage with the Industry to Promote MIL?" 
solaci -